Skip to search formSkip to main contentSkip to account menu

travoprost

Known as: 5-Heptenoic Acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl Ester,(5Z)-, Travoprost [Chemical/Ingredient], Travoprostum 
A synthetic lipophilic isopropyl ester prodrug of the active compound travoprost free acid, a prostaglandin F2alpha analog with anti-glaucoma… 
National Institutes of Health

Related topics

Related topics

17 relations

Narrower (3)

AL-6221TravatanTravatan Z

Broader (1)

Antihypertensive Agents
Drug AllergyGlaucoma, Open-AngleIn BloodPregnancy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways.
Highly Cited
2008
Highly Cited
2008
Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
Highly Cited
2006
Highly Cited
2006
Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
Highly Cited
2005
Highly Cited
2005
In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
PURPOSE In a previous study, it was demonstrated that in vitro in a human conjunctiva-derived cell line, latanoprost in its… 
Highly Cited
2005
Highly Cited
2005
A Three-Month, Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Compared to Travoprost 0.004% Ophthalmic Solution and Timolol 0.5…
Purpose:The primary objective of this study was to compare the intraocular pressure (IOP)-lowering efficacy of travoprost 0.004… 
Highly Cited
2003
Highly Cited
2003
Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
PURPOSE To determine the functional agonist potencies of the intraocular pressure (IOP)-lowering prostaglandin F (FP)-class… 
Highly Cited
2003
Highly Cited
2003
Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
Highly Cited
2002
Highly Cited
2002
Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
We have determined the agonist activity of a number of natural prostaglandins and prostaglandin analogs at the FP prostaglandin… 
Review
2002
Review
2002
New Glaucoma Medications in the Geriatric Population: Efficacy and Safety
Glaucoma can be considered a disease of the aging eye. Most medications used to treat glaucoma are in topical eyedrop form and… 
Highly Cited
2001
Highly Cited
2001
Comparison of Topical Travoprost Eye Drops Given Once Daily and Timolol 0.5% Given Twice Daily in Patients with Open-Angle Glaucoma or Ocular Hypertension
PurposeThis 9-month study compared the intraocular pressure (IOP)-lowering efficacy and safety of once-daily travoprost… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)